Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan-Long Chuang

Showing results (181-190 of 456) with videos related to

Pageof 46
Sort By:
The Journal of Antimicrobial Chemotherapy|June 27, 2013
Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre studyChia-Yen Dai, Tai-Chung Tseng, Grace Lai Hung Wong, et al.
Journal of Hepatology|December 26, 2009
Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in TaiwanChia-Yen Dai, Chi-Kung Ho, Jee-Fu Huang, et al.
Scandinavian Journal of Infectious Diseases|April 11, 2009
Performance characteristics of two real-time PCR assays for quantification of hepatitis B virus DNAYa-Yun Lin, Jee-Fu Huang, Shu-Fen Liu, et al.
The Kaohsiung Journal of Medical Sciences|July 25, 2016
The performance of acoustic radiation force impulse imaging in predicting liver fibrosis in chronic liver diseasesYi-Hung Lin, Ming-Lun Yeh, Ching-I Huang, et al.
Hepatology International|November 11, 2010
Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patientsChung-Feng Huang, Ming-Yen Hsieh, Jeng-Fu Yang, et al.
Medicine|July 12, 2016
Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapyChung-Feng Huang, Ming-Lun Yeh, Cing-Yi Huang, et al.
The Journal of Infectious Diseases|December 3, 2005
Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infectionChia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
Hepatology International|July 24, 2015
The safety and efficacy of peginterferon plus ribavirin in hepatitis C patients concomitant with malignancy other than hepatocellular carcinoma: a multicenter studyChung-Feng Huang, Jee-Fu Huang, Wu-Cheng Chen, et al.
Hepatology (Baltimore, Md.)|October 24, 2006
A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapyMing-Lung Yu, Shi-Ming Lin, Chuan-Mo Lee, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 18, 2003
Clinical significance of TT virus (TTV) infection in chronic hepatitis C patients with high dose interferon-alpha therapy in Taiwan: re-evaluated by using new set of TTV primersChia Yen Dai, Ming Lung Yu, Zu Yau Lin, et al.
Pageof 46

Showing results (181-190 of 456) with videos related to

Sort By:
Pageof 46
The Journal of Antimicrobial Chemotherapy|June 27, 2013
Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre studyChia-Yen Dai, Tai-Chung Tseng, Grace Lai Hung Wong, et al.
Journal of Hepatology|December 26, 2009
Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in TaiwanChia-Yen Dai, Chi-Kung Ho, Jee-Fu Huang, et al.
Scandinavian Journal of Infectious Diseases|April 11, 2009
Performance characteristics of two real-time PCR assays for quantification of hepatitis B virus DNAYa-Yun Lin, Jee-Fu Huang, Shu-Fen Liu, et al.
The Kaohsiung Journal of Medical Sciences|July 25, 2016
The performance of acoustic radiation force impulse imaging in predicting liver fibrosis in chronic liver diseasesYi-Hung Lin, Ming-Lun Yeh, Ching-I Huang, et al.
Hepatology International|November 11, 2010
Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patientsChung-Feng Huang, Ming-Yen Hsieh, Jeng-Fu Yang, et al.
Medicine|July 12, 2016
Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapyChung-Feng Huang, Ming-Lun Yeh, Cing-Yi Huang, et al.
The Journal of Infectious Diseases|December 3, 2005
Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infectionChia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
Hepatology International|July 24, 2015
The safety and efficacy of peginterferon plus ribavirin in hepatitis C patients concomitant with malignancy other than hepatocellular carcinoma: a multicenter studyChung-Feng Huang, Jee-Fu Huang, Wu-Cheng Chen, et al.
Hepatology (Baltimore, Md.)|October 24, 2006
A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapyMing-Lung Yu, Shi-Ming Lin, Chuan-Mo Lee, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 18, 2003
Clinical significance of TT virus (TTV) infection in chronic hepatitis C patients with high dose interferon-alpha therapy in Taiwan: re-evaluated by using new set of TTV primersChia Yen Dai, Ming Lung Yu, Zu Yau Lin, et al.
Pageof 46